0001578563-22-000016.txt : 20220519
0001578563-22-000016.hdr.sgml : 20220519
20220519160116
ACCESSION NUMBER: 0001578563-22-000016
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220518
FILED AS OF DATE: 20220519
DATE AS OF CHANGE: 20220519
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sirgo Mark A
CENTRAL INDEX KEY: 0001301715
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37797
FILM NUMBER: 22942734
MAIL ADDRESS:
STREET 1: C/O BIODELIVERY SCIENCES INTERNATIONAL
STREET 2: 801 CORPORATE CENTER DRIVE -SUITE 210
CITY: RALEIGH
STATE: NC
ZIP: 27607
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 9 METERS BIOPHARMA, INC.
CENTRAL INDEX KEY: 0001551986
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273948465
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8480 HONEYCUTT ROAD
STREET 2: SUITE 120
CITY: RALEIGH
STATE: NC
ZIP: 27615
BUSINESS PHONE: 919-275-1933
MAIL ADDRESS:
STREET 1: 8480 HONEYCUTT ROAD
STREET 2: SUITE 120
CITY: RALEIGH
STATE: NC
ZIP: 27615
FORMER COMPANY:
FORMER CONFORMED NAME: INNOVATE BIOPHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20180201
FORMER COMPANY:
FORMER CONFORMED NAME: Monster Digital, Inc.
DATE OF NAME CHANGE: 20150930
FORMER COMPANY:
FORMER CONFORMED NAME: Tandon Digital, Inc.
DATE OF NAME CHANGE: 20120611
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2022-05-18
0
0001551986
9 METERS BIOPHARMA, INC.
NMTR
0001301715
Sirgo Mark A
C/O 9 METERS BIOPHARMA, INC.
8480 HONEYCUTT ROAD, SUITE 120
RALEIGH
NC
27615
1
0
0
0
Common Stock
2022-05-18
4
P
0
106383
0.47
A
1385427.55
D
Common Stock
21485
I
By spouse
The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $0.46 to $0.47 inclusive. The reporting person undertakes to provide to 9 Meters Biopharma, Inc., any security holder of 9 Meters Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
/s/Bethany Sensenig, as power of attorney
2022-05-19